Akari Therapeutics Plc (AKTX) Slipped -6.58% or -0.15 To Price $2.13 On Tuesday


Akari Therapeutics Plc (AKTX) slipped -6.58% or -0.15 to $2.13. It is close to 44818 shares traded, which is 72.89% compare to the average total volume 61484. The market cap of AKTX is $32.50 million. The year to date change is -48.06%. The 52 week price range is from $1.7 to $12.49. Price of AKTX have changed 14.57% during last week. It have changed 20.00% over last month, 4.11% over last 3 months, -44.12% over last 6 months and -80.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKTX is 2.02. It is -5.16% below current price. The 200-day Moving Averages for AKTX is 3.77. It is 77.00% above current price. The 52-week High is 12.49. It is 486.38% from the current price. The 52-week Low is 1.7. It is -20.19% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKTX is 3.52 on 2018-04-13. Short % to float is 2.85%. There are some statistics of AKTX. It is has market cap $32.50 million. The share outstanding is 15.26 million. The average volume is 61484. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKTX is -120.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKTX is -86.95%.


Tags:

Share this post